SIRT3 and colorectal cancer: SIRT1 overexpression has been noted in several cancers, including prostate, AML and colorectal cancer [17–19], whilst SIRT3 and SIRT7 levels have been demonstrated to be overexpressed in node-positive breast cancer [9].